• Leading Linearized DNA Platform
• Two manufacturing options: provide optimal solutions
As mRNA technology is widely used in the prevention and treatment of various diseases including cancer, influenza, genetic diseases, etc., the demand for production from template plasmids to mRNA has also increased rapidly. As a leading plasmid CDMO, GenScript ProBio can provide customers with one-stop services for plasmids and linearized DNA from preclinical to commercial stages.
GenScript ProBio's linearized DNA platform has two sets of mature production processes, which provide optimal solutions with various enzymes according to different projects. At present, GenScript ProBio has assisted many global customers to obtain IND approvals and produced multiple batches of clinical samples.
High copy plasmid: process 1.0
Low copy plasmid: ProPlusTM